More stock info

Investor FAQs

Home  >  Investor Resources  >  Investor FAQs

On which stock exchange do you trade?

Elanco’s stock trades on the New York Stock Exchange (NYSE).

back to top

What is your ticker symbol?

Elanco’s ticker symbol is “ELAN”.

back to top

Who is your transfer agent?

Elanco has authorized Computershare Trust Company, N.A. as its transfer agent.

back to top

What does a transfer agent do?

Transfer agents maintain stock registries for their client companies such as Elanco. They assist with account information and updates, processing and paying dividends, registration changes, transferring stock, and answering questions from shareholders about their accounts.

back to top

How do I contact your transfer agent?

You may contact Computershare by calling:
(800) 736-3001 (US, Canada, Puerto Rico)
(781) 575-3100 (non-US)

Correspondence should be mailed to:
P.O. Box 505000
Louisville, KY 40233-5000

Overnight correspondence should be mailed to:
462 South 4th Street, Suite 1600
Louisville KY 40202

Be sure to include your name, address, day time phone number, account number, company name (as shown on your statement) on all correspondence.

E-mail and online inquiries may be directed to:
Email Inquiries:
Online Inquiries:

back to top

Does your company pay a dividend?

We do not anticipate paying dividends on our common stock in the foreseeable future.

back to top

Do you have a dividend reinvestment plan (DRIP)?

At this time, Elanco does not have a dividend reinvestment plan.

back to top

How do I contact the company’s investor relations department?

Contact our investor relations department by mail at:
Elanco Animal Health Incorporated
Attn: Investor Relations Department
2500 Innovation Way
Greenfield, IN 46140

Or contact by email at

back to top

Where are your corporate offices?

Elanco’s corporate offices are located at:
2500 Innovation Way
Greenfield, IN 46140

back to top

When does your company’s fiscal year end?

Elanco’s fiscal year ends on December 31.

back to top

Who are your company’s independent auditors?

Ernst & Young serves as the company’s independent auditors.

back to top

What is the status of the Aratana CVR?

Elanco finalized the acquisition of Aratana Therapeutics on July 18, 2019. At the close of the stock-for-stock transaction, Aratana stockholders received 0.1481 shares of Elanco common stock and one contingent value right (CVR) for each share of Aratana common stock. The CVR of $0.25 per Aratana share will be paid in cash if capromorelin achieves certain sales levels on or before the end of 2021. Elanco will update the investment community as milestones are met.

back to top